Edoxudine

Edoxudine

Systematic (IUPAC) name
5-ethyl-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
Identifiers
CAS Number	15176-29-1
ATC code	D06BB09 (WHO)
PubChem	CID 66377
ChemSpider	59752
UNII	15ZQM81Y3R
ChEMBL	CHEMBL318153
Chemical data
Formula	C11H16N2O5
Molar mass	256.25514
SMILES O=C/1NC(=O)N(\C=C\1CC)[C@@H]2O[C@@H]([C@@H](O)C2)CO
InChI InChI=1S/C11H16N2O5/c1-2-6-4-13(11(17)12-10(6)16)9-3-7(15)8(5-14)18-9/h4,7-9,14-15H,2-3,5H2,1H3,(H,12,16,17)/t7-,8+,9+/m0/s1 Key:XACKNLSZYYIACO-DJLDLDEBSA-N
(what is this?)  (verify)

Edoxudine (or edoxudin) is an antiviral drug. It is an analog of thymidine, a nucleoside.

It has shown effectiveness against herpes simplex virus.^[1]

Synthesis

Edoxudine synthesis:^[2] Synthesis via organopalladium intermediates:^[3][4]

Mercuration of the 2'-deoxyuridine 1 leads to the organometallic derivative 2; reaction of that with ethylene in the presence dilithiopalladium tetrachloride gives the alkylation product 3; this is reduced catalytically in situ. There is thus obtained the antiviral agent edoxudine 4.

References

1. "Topical antiviral agents for herpes simplex virus infections". Drugs Today 34 (12): 1013–25. December 1998. doi:10.1358/dot.1998.34.12.487486. PMID 14743269.
2. K. K. Gauri, GB 1170565; eidem, U.S. Patent 3,553,192 (1968, 1971 both to Robugen).
3. Bergstrom, Donald E.; Ruth, Jerry L. (1976). "Synthesis of C-5 substituted pyrimidine nucleosides via organopalladium intermediates". Journal of the American Chemical Society 98 (6): 1587–9. doi:10.1021/ja00422a056. PMID 1249369.
4. Bergstrom, Donald E.; Ogawa, Mark K. (1978). "C-5 substituted pyrimidine nucleosides. 2. Synthesis via olefin coupling to organopalladium intermediates derived from uridine and 2'-deoxyuridine". Journal of the American Chemical Society 100 (26): 8106–8112. doi:10.1021/ja00494a014. ISSN 0002-7863.